Quantification of different human alpha interferon subtypes and pegylated interferon activities by measuring MxA promoter activation

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 9, 2005, Pages 3770-3775

  François, Catherine ^a   Bernard, Isabelle ^a   Castelain, Sandrine ^a   Charleston, Bryan ^b   Fray, Martin D ^b   Capiod, Jean Claude ^a   Duverlie, Gilles ^a,c  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^c UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CHLORAMPHENICOL ACETYLTRANSFERASE; MYXOVIRUS RESISTANCE PROTEIN A; PEGINTERFERON; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RECOMBINANT ALPHA2A INTERFERON; RIBAVIRIN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; BIOASSAY; CAT GENE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE ACTIVATION; HEPATITIS C; HUMAN; IMMUNOMODULATION; MXA GENE; NONHUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SECRETION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; REPORTER GENE; REPRODUCIBILITY;

ANIMALS; ANTIVIRAL AGENTS; BIOLOGICAL ASSAY; CELL LINE; CHLORAMPHENICOL O-ACETYLTRANSFERASE; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GTP-BINDING PROTEINS; HEPATITIS C; HUMANS; INTERFERON TYPE I, RECOMBINANT; POLYETHYLENE GLYCOLS; PROMOTER REGIONS (GENETICS); REPRODUCIBILITY OF RESULTS;

EID: 24144491592     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.9.3770-3775.2005     Document Type: Article

References (18)

1. Aebi, M., J. Fah, N. Hurt, C. E. Samuel, D. Thomis, L. Bazzigher, J. Pavlovic, O. Haller, and P. Staeheli. 1989. cDNA structures and regulation of two intcrferon-induced human Mx proteins. Mol. Cell. Biol. 9:5062-5072.
2. Boulestin, A., N. Kamar, F. Legrand-Abravanel, K. Sandres-Saune, L. Alric, J. P. Vinel, L. Rostaing, and J. Izopet. 2004. Convenient biological assay for polyethylene glycol-interferons in patients with hepatitis C. Antimicrob. Agents Chemother. 48:3610-3612.
3. Der, S. D., A. Zhou, B. R. Williams, and R. H. Silverman. 1998. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonuclcotide arrays. Proc. Natl. Acad. Sci. USA 95:15623-15628.
4. Ellinwood, N. M., J. M. McCue, P. W. Gordy, and R. A. Bowen. 1998. Cloning and characterization of cDNAs for a bovine (Bos taurus) Mx protein. J. Interferon Cytokine Res. 18:745-755.
5. Fray, M. D., G. E. Mann, and B. Charleston. 2001. Validation of an Mx/CAT reporter gene assay for the quantification of bovine typc-1 interferon. J. Immunol. Methods 249:235-244.
6. Haller, O., M. Frese, and G. Kochs. 1998. Mx proteins: mediators of innate resistance to RNA viruses. Rev. Sci. Technol. 17:220-230.
7. Heney, D., and J. T. Whicher. 1995. Factors affecting the measurement of cytokines in biological fluids: implications for their clinical measurement. Ann. Clin. Biochem. 32:358-368.
8. Levy, D. E., and A. Garcia-Sastre. 2001. The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion. Cytokine Growth Factor Rev. 12:143-156.
9. Meager, A. 2002. Biological assays for interferons. J. Immunol. Methods 261:21-36.
10. Ronni, T., S. Matikainen, A. Lehtonen, J. Palvimo, J. Dellis, F. Van Eylen, J. F. Goetschy, M. Horisberger, J. Content, and I. Julkunen. 1998. The proximal interferon-stimulated response elements are essential for interferon responsiveness: a promoter analysis of the antiviral MxA gene. J. Interferon Cytokine Res. 18:773-781.
11. Rubinstein, S., P. C. Familletti, and S. Pestka. 1981. Convenient assay for interferons. J. Virol. 37:755-758.
12. Samuel, C. E. 2001. Antiviral actions of interferons. Clin. Microbiol. Rev. 14:778-809.
13. Staeheli, P., F. Pitossi, and J. Pavlovic. 1993. Mx proteins: GTPases with antiviral activity. Trends Cell Biol. 3:268-272.
14. Vrolijk, J. M., A. Kaul, B. E. Hansen, V. Lohmann, B. L. Haagmans, S. W. Schalm, and R. Bartenschlager. 2003. A replicon-based bioassay for the measurement of interferons in patients with chronic hepatitis C. J. Virol. Methods 110:201-209.
15. Yamamoto, S., H. Yano, O. Sanou, H. Ikegami, M. Kurimoto, and M. Kojiro. 2002. Different antiviral activities of IFN-alpha subtypes in human liver cell lines: synergism between IFN-alpha2 and IFN-alpha8. Hepatol. Res. 24:99.
16. Yamaoka, T., S. Kojima, S. Ichi, Y. Kashiwazaki, T. Koide, and Y. Sokawa. 1999. Biologic and binding activities of IFN-alpha subtypes in ACHN human renal cell carcinoma cells and Daudi Burkitt's lymphoma cells. J. Interferon Cytokine Res. 19:1343-1349.
17. Yanai, Y., O. Sanou, T. Kayano, H. Ariyasu, K. Yamamoto, H. Yamauchi, H. Ikegami, and M. Kurimoto. 2001. Analysis of the antiviral activities of natural IFN-alpha preparations and their subtype compositions. J. Interferon Cytokine Res. 21:835-841.
18. Zeuzem, S., S. V. Feinman, J. Rasenack, E. J. Heathcote, M. Y. Lai, E. Gane, J. O'Grady, J. Reichen, M. Diago, A. Lin, J. Hoffman, and M. J. Brunda. 2000. Peginterferon alfa-2a in patients with chronic hepatitis C. N. Engl. J. Med. 343:1666-1672.